Qube Research & Technologies LTD Eq Rx, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.66 - $2.31 $6.63 Million - $9.22 Million	3,992,747 New	3,992,747 $8.86 Million
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.69 $1.16 Million - $2.06 Million	-361,434 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$2.8 - $7.39 $211,114 - $557,191	75,398 Added 26.36%	361,434 $1.49 Million
Q4 2021 Feb 01, 2022	BUY	$5.92 - $9.98 $1.69 Million - $2.85 Million	286,036 New	286,036 $1.95 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.